Last updated on March 2020

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Brief description of study

This research study will examine the safety and effectiveness of ONS-5010 in participants with AMD. The goal is to prevent vision loss by evaluating the effectiveness of ONS-5010 as compared with ranibizumab.

Clinical Study Identifier: NCT03834753

Find a site near you

Start Over

Clinical Site

Sarasota, FL United States
  Connect »